Syros Pharmaceuticals, Inc. (SYRS)
OTCMKTS · Delayed Price · Currency is USD
0.0022
+0.0011 (100.00%)
Sep 8, 2025, 2:36 PM EDT
Syros Pharmaceuticals Market Cap
Syros Pharmaceuticals has a market cap or net worth of $29.52 thousand as of September 8, 2025. Its market cap has decreased by -99.94% in one year.
Market Cap
29.52K
Enterprise Value
1.98M
Revenue
386.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since June 30, 2016, Syros Pharmaceuticals's market cap has decreased from 413.10M to 29.52K, a decrease of -99.99%. That is a compound annual growth rate of -64.62%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 5, 2025 | 29.52K | -99.52% |
Dec 31, 2024 | 6.17M | -96.96% |
Dec 29, 2023 | 202.59M | 179.01% |
Dec 30, 2022 | 72.61M | -64.04% |
Dec 31, 2021 | 201.95M | -59.37% |
Dec 31, 2020 | 497.05M | 69.48% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Jun 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Nika Pharmaceuticals | 982.68M |
Veradigm | 825.37M |
Elite Pharmaceuticals | 742.62M |
Tian'an Technology Group | 705.53M |
Glass House Brands | 600.85M |
CytoDyn | 396.74M |
Northwest Biotherapeutics | 376.41M |
American Oncology Network | 353.52M |